Vaasa Central Hospital
Vasa Centralsjukhus - Vaasan Keskussairaala

Finland

1 June 2019 - 31 May 2020

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Vaasa Central Hospital published between 1 June 2019 - 31 May 2020 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Count Share
3 0.01

Outputs by subject (Share)

Subject Count Share
Life Sciences 3 0.01

1 June 2019 - 31 May 2020

International vs. domestic collaboration by Share

  • 42.94% Domestic
  • 57.06% International

Note: Hover over the graph to view the percentage of collaboration.

Top 10 domestic collaborators by Share (33 total)

  • Vaasa Central Hospital, Finland
  • Domestic institution
  1. Institute for Molecular Medicine Finland (FIMM), Finland (0.27)
    0.01
    0.26
  2. Finland Ministry of Social Affairs and Health, Finland (0.20)
    0.01
    0.19
  3. The Hospital District of Helsinki and Uusimaa (HUS), Finland (0.20)
    0.01
    0.19
  4. Northern Ostrobothnia Hospital District (NOHD), Finland (0.12)
    0.01
    0.11
  5. University of Eastern Finland (UEF), Finland (0.11)
    0.01
    0.10
  6. University of Helsinki, Finland (0.10)
    0.01
    0.09
  7. Pirkanmaa Hospital District, Finland (0.09)
    0.01
    0.08
  8. Hospital District of Southwest Finland, Finland (0.08)
    0.01
    0.08
  9. Medical Research Center Oulu (MRC Oulu), Finland (0.08)
    0.01
    0.07
  10. VTT Technical Research Centre of Finland Ltd., Finland (0.06)
    0.01
    0.05

Top 10 international collaborators by Share (249 total)

  • Vaasa Central Hospital, Finland
  • Foreign institution
  1. F. Hoffmann-La Roche AG, Switzerland (0.17)
    0.01
    0.16
  2. AbbVie Inc., United States of America (USA) (0.15)
    0.01
    0.15
  3. Pfizer Inc., United States of America (USA) (0.12)
    0.01
    0.11
  4. Merck & Co., Inc., United States of America (USA) (0.12)
    0.01
    0.11
  5. GlaxoSmithKline plc. (GSK), United Kingdom (UK) (0.09)
    0.01
    0.08
  6. Sanofi, France (0.07)
    0.01
    0.07
  7. Biogen Inc., United States of America (USA) (0.07)
    0.01
    0.06
  8. Bristol-Myers Squibb (BMS), United States of America (USA) (0.06)
    0.01
    0.06
  9. European Molecular Biology Laboratory (EMBL), Germany (0.06)
    0.01
    0.05
  10. Harvard University, United States of America (USA) (0.05)
    0.01
    0.04

Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.

Creative Commons License

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Return to institution outputs

Except where otherwise noted © 2020 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER